News

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, ...
In a recent study, researchers have uncovered the biological trigger behind the dangerous immune-related adverse events ...
Abstract:        Obesity, a growing global issue, has been closely associated with an increased risk of various cancers, especially breast cancer. El ...
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions ...
A study has found that switching from a high-fat diet to a low-fat diet can help reduce the risk of pancreatic cancer.
Understanding the molecular and cellular underpinnings of human disease is crucial for the development of effective ...
A study in Oncogene shows that PPP2R1A mutations increase sensitivity to ATR inhibitors in ARID1A-mutant ovarian clear cell ...
This study provides useful information on the impact of Lamin A/C knockdown on gene expression using RNA-Seq analysis. In addition, the impact of Lamin A/C knockdown on telomere dynamics is explored ...
Sagimet Biosciences' FASN inhibitors show promise in acne and metabolic disease. Read my analysis on SGMT stock and see why I ...
In a study published in Nature Communications, Dr. Eiji Yoshihara, PhD, investigator at The Lundquist Institute for ...
The order, which primarily targets countries in Africa and the Middle East, revives an effort from President Trump’s first ...
Innovation in clinical diagnostics is accelerating, with breakthroughs that promise to make testing more precise, less invasive and more accessible. These advancements are expected not only to benefit ...